Delivery Order SPE2DB24D2205-SPE2DB25FEGCC
- Not listed
- The Defense Logistics Agency awarded a $2,155.93 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based injection used for knee osteoarthritis treatment, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,892.93 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity) under a firm fixed price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based viscosupplement used for...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.73 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML syringes (4 ML quantity) on August 12, 2025, with a completion date of August 13, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This firm fixed price delivery order, valued at $7,229.88, represents a non-set-aside award and is due for completion by August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Monovisc is a viscosupplement injection used in orthopedic and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $9,152.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,266.96 on July 18, 2025, for the supply of MONOVISC 88 mg/4 mL syringes (4 mL quantity) under a firm fixed-price contract. The award, which carries an ultimate completion date of July 21, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the company's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $9,013.11 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract is a firm fixed-price delivery order with a completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $2,194.02 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX),...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGCCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,711.30 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supplies to be performed at the awardee's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid injection used for joint pain management, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need for diverse pharmaceutical and medical products supporting military healthcare operations. This delivery order is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp leverages this prime contract vehicle to supply a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill specialized medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/11/25 |